Prostate cancer: Psychosocial implications and management
Open accessAbstract
This review summarizes some of the key psychosocial issues related to prostate cancer, both generally and for an older adult population. It focuses on three main areas: quality-of-life issues, psychosocial implications and management of these psychosocial issues. Broadly, the article presents information on the general background, screening guidelines, common side effects of treatment and current psychiatric and psychological management strategies in prostate cancer. The article addresses the clinical approaches, as well as the complexities that surface when deciding the treatment for patients with prostate cancer. Clinical and future implications are also discussed. © 2008 Future Medicine Ltd.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
9 of 47 cited sources checked · 1 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Androgen ablation therapy also affects cognitive functioning.
“Recently, review articles discussing the side effects of androgen ablation therapy have stated that this treatment also impacts cognitive functioning [9, 11].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [9]
- cites [11] source
- Premisecitation
Education and awareness about problems can significantly lower psychological stress.
“Though there may be considerable variations between the patients’ and urologists’ evaluation of performance status, pain, and pain relief [17], awareness and education about these problems as well as continued attempts to resolve them, or to cope better with them, can significantly reduce psychological stress [18].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] source
The Discussion reports that preoperative nursing interventions have had a positive effect on anxiety, and the Conclusion calls for further education about the psychological consequences of radical prostatectomy. The paper does not establish that education and awareness themselves significantly reduce psychological stress; it identifies targeted interventions as a goal for future research. (LLM, conf=0.81)
Experimental — accuracy not yet measured
- Premisecitation
Reported rates of erectile dysfunction after prostatectomy vary widely, from 29% to 85%.
“Unfortunately, a wide variation in rates of erectile dysfunction following prostatectomy have been reported in the literature and range from 29 to 85% [23].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [23] source
The paper discusses widely differing estimates of erectile function after prostatectomy and reports that 85% of its respondents had an erectile-dysfunction problem, but that sample included men treated with surgery or radiation. Its discussion of published post-treatment rates gives a 50–80% range for surgery or radiation together, not a 29–85% range specifically after prostatectomy. The cited copy therefore supports the general point about variation, but not the stated endpoints and population. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
In men aged 40 to 70, there is a significant relationship between erectile dysfunction and depression, with odds ratios ranging from 1.7 to 1.8.
“In men who range in age from 40 to 70, these researchers found a significant relationship between the presence of ED and depression (ORs ranging from 1.7 to 1.8).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [41] source
- cites [42] source
The Results describe men aged 36–82, not an analysis limited to ages 40–70. Searches for depression and odds ratios found no passage reporting an association between erectile dysfunction and depression or ORs of 1.7–1.8; the paper mentions distress but does not establish the claimed relationship. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Megace has been found helpful for hot flashes.
“Megace, a synthetic, antineoplastic and progestational drug., has also been found to be helpful [51].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [51] source
The paper mentions hot flashes as a source of distress in men with prostate cancer, but does not say Megace helps treat them. A reference lists a report about sertraline relieving hot flashes; searches for Megace, megestrol acetate, and hot-flash treatment found no supporting passage. The indexed copy provides no page numbers for these passages. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
For early-stage prostate cancer, the main treatment options-radical prostatectomy, radiation therapy, and active surveillance-can produce different outcomes in sexual, urinary, or bowel function over time.
“For early stage cancer, primary treatment options are radical prostatectomy, radiation therapy, and active surveillance, which can lead to differences in specific areas of functioning, such as sexual, urinary or bowel functioning over time [2, 3].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [2] source
- cites [3] source
The opening section lists prostatectomy, radiotherapy, and conservative management among the choices for clinically localized prostate cancer. The Discussion reports differences in urinary, bowel, and sexual function over five years after prostatectomy or external-beam radiotherapy. It does not identify active surveillance specifically or compare its functional outcomes with those treatments. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Urinary incontinence can be alleviated with pelvic muscle re-education, bladder training, anticholinergic medications, and artificial sphincter surgery.
“Urinary incontinence can be alleviated with pelvic muscle re-education, bladder training, anticholinergic medications, and even artificial sphincter surgery [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] source
- Premisecitation
Potency rates after external beam radiation therapy are 96%, 75%, 59%, and 53% at 1, 20, 40, and 60 months, respectively.
“These authors noted the potency rates of 96%, 75%, 59% and 53% at 1, 20, 40 and 60 months after external beam radiation therapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] source
- Premisecitation
Men who achieve consistent erections after radical prostatectomy have a greater chance of retaining erectile function when nerves fully heal at 18 to 24 months.
“Initial data suggest that following radical prostatectomy men who achieve consistent erections have an increased chance of retaining erectile function when the nerves are fully healed at 18 to 24 months post-surgery [33, 34].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In men, hot flashes are caused by many hormonal therapies, including orchiectomy.
“In men, hot flashes are caused by many of the hormonal therapies, including orchiectomy [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] source
- Premisecitation
Recovery of erections after unilateral nerve-sparing surgery ranges from 13% to 56%.
“erections in men who had bilateral nerve-sparing surgery range from 31 to 86% [26, 27], while those who had unilateral nerve-sparing surgery report recovery of erections in 13 to 56% of the cases [27, 28].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Supportive psychotherapy and cognitive behavioral therapy can help men cope with lifestyle changes.
“Both supportive psychotherapy and cognitive behavioral therapy [46] can assist a man in coping with these changes in lifestyle.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46]
- Premisecitation
Recovery of erections after bilateral nerve-sparing surgery ranges from 31% to 86%.
“The rates of recovery of erections in men who had bilateral nerve-sparing surgery range from 31 to 86% [26, 27], while those who had unilateral nerve-sparing surgery report”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The erectile dysfunction rate after radical prostatectomy in the general urologic population is 81%.
“In a recent review, Dubbelman et al. [25] concluded that the ED rate after radical prostatectomy in the general urologic population is 81% [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] source
- Premisecitation
Anecdotal reports and small trials suggest that SSRIs such as sertraline and paroxetine, or the SNRI venlafaxine, reduce the frequency and intensity of hot flashes.
“There have been anecdotal reports and small trials that suggest antidepressants, particularly the serotonin reuptake inhibitors (SSRI’s), such as sertraline (Zoloft), and paroxetine (Paxil), or the serotonin-norepinephrine reuptake inhibitor (SNRI), such as venlafaxine (Effexor) to reduce the frequency and intensity of hot flashes [e.g. 49, 50].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [50] source
- Premisecitation
Nerve-sparing prostatectomy has reduced the rates of impotence and urinary incontinence.
“Urologists typically will perform a “nerve-sparing” procedure that has decreased the rate of complications of impotence and urinary incontinence [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] source
- Premisecitation
After nerve-sparing surgery, the nerves may require at least 18 to 24 months to fully heal.
“The data suggests even when the nerves are sparred during surgery, the nerves may take at least 18 to 24 months to fully heal [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] source
- Premisecitation
Spouses experience significant distress in coping with their husbands' prostate cancer.
“It has been noted that spouses suffer significant distress coping with their husbands’ prostate cancer [57, 58].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Anxiety is the most frequently experienced psychiatric symptom in men with prostate cancer.
“Psychiatrically, anxiety tends to be the most often experienced symptom for men with prostate cancer [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] source
- Premisecitation
A prior history of depression is the strongest predictor of depressive symptoms in men with prostate cancer.
“Many men may also report irritability or depression, and the leading predictor of depressive symptoms has been found to be a previous history of depression [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] source
- Premisecitation
At 3 to 5 years after treatment, erectile dysfunction rates are similar between radiation and surgery groups.
“As a result, when you examine the data from 3 to 5 years post treatment the rates of ED are similar between the radiation and surgery groups [29].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] source
- Premisecitation
Urinary incontinence has been rated as a more bothersome outcome than erectile dysfunction.
“In fact, urinary incontinence has been rated a more bothersome outcome than ED [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
- Premisecitation
Brachytherapy patients still reported a significant decline in sexual function from their baseline scores.
“It is important to note that the brachytherapy patients still reported a significant decline in sexual function from their baseline scores.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] source
- May combine two claims. 9
- Classified as probably not a substantial claim. 1
May combine two claims.
PremisecitationHormonal therapy side effects include hot flashes, osteoporosis, anemia, fatigue, sarcopenia, gynecomastia, loss of libido, erectile dysfunction, diabetes risk, cardiovascular disease risk, fatal cardiac events, and possible emotional distress.
“These side effects include: hot flashes, osteoporosis, anemia, fatigue, sarcopenia, gynecomastia, loss of libido, erectile dysfunction, risk of diabetes, risk of cardiovascular disease and fatal cardiac events as well as possible emotional distress [9–13].”
Quote in the paperNot a substantial claim3 of 5 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10] source
- cites [11] source
The Andropause and Prostate Cancer, Sarcopenia, and Sexual Dysfunction sections support most of the listed effects of hormonal ablation, including hot flashes, osteoporosis, anemia, fatigue, muscle loss, gynecomastia, reduced sexual desire, erectile difficulties, and depression. The Osteoporosis and Vasomotor Symptoms sections associate cardiovascular effects specifically with estrogen therapy; the cited paper does not establish diabetes risk or fatal cardiac events as side effects of hormonal ablation generally. Page numbers were not supplied in our copy. (LLM, conf=0.89)
Experimental — accuracy not yet measured - cites [12] source
The Discussion (page unavailable) reports that GnRH agonist therapy was associated with increased risks of diabetes, cardiovascular disease, and sudden cardiac death in older men with local or regional prostate cancer. The paper does not substantiate the other listed side effects, such as hot flashes, anemia, sexual dysfunction, or emotional distress; its findings also concern GnRH agonists rather than hormonal therapy generally. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [13] source
The Introduction associates androgen suppression therapy with anemia, insulin resistance, and increased diagnoses of cardiac disease. The Discussion reports earlier fatal myocardial infarctions in men aged 65 or older receiving the therapy. Our copy does not substantiate the sentence’s other listed effects, such as hot flashes, osteoporosis, sexual dysfunction, or emotional distress; no page numbers are available in the indexed passages. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationErectile dysfunction can result from aging, the cancer itself, surgery, radiation, and hormonal therapy.
“Erectile dysfunction, a complication feared by many men diagnosed with prostate cancer, can occur from aging, the cancer itself, surgery, radiation, and hormonal therapy [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
May combine two claims.
PremisecitationRadiation therapy may cause less urinary leakage but carries higher risks of urinary voiding difficulties and bowel problems, depending on technique and total dose.
“Radiation therapy, either conventional or brachytherapy with seed implants, may yield less incidence of urinary leakage; however, there are more risks of urinary voiding difficulties with radiation treatments and difficulties with bowel function depending on factors of technique and total dose delivered [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] source
May combine two claims.
PremisecitationStudies have found that couples in which the male partner reported erectile dysfunction also reported less intimate contact and lower scores on togetherness and tenderness.
“Preliminary data exists to support these clinical observations; studies have found the couples where the male partner reported ED also reported less intimate contact, and lower scores on togetherness and tenderness within the relationship [43, 44]”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationPSA anxiety can lead to panic symptoms and insomnia, and may be relieved with education, support, and anxiolytic medications if needed.
“This PSA anxiety [52, 53, 54] can lead to panic symptoms and insomnia, and may be relieved with education, support and anxiolytic medications if needed.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationPenile implants are an effective option, and most patients report very high satisfaction with this treatment.
“If these treatments are not effective or satisfactory to the patient, penile implants are an effective option and most patients report very high satisfaction with this treatment [38].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] source
May combine two claims.
PremisecitationShabsigh and colleagues found a depression rate of 56% in men with erectile dysfunction, significantly higher than the 21% rate in men with benign prostatic hyperplasia.
“Shabsigh and colleagues [40] (1998) found that the rate of depression was extremely high in men with ED (56%) and was significantly higher than in men in the control group with benign prostatic hyperplasia (BPH) (21%) [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEstimates of anxiety in men with prostate cancer are around 33%, while depression estimates range from 12% to 15%.
“Estimates of anxiety in men with prostate cancer have hovered around 33% [54], while depression has been estimated between 12 and 15%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] source
May combine two claims.
PremisecitationFibrosis continues to develop for up to about 3 years after radiation and interferes with the neurovascular bundles and blood vessels needed for erections.
“However, fibrosis continues to develop up to approximately 3 years past radiation and interferes with the neurovascular bundles and blood vessels adjacent to the prostate necessary for erections [29].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] source
The authors state this as an assumption.
Men are typically the ones who initiate sexual contact within a relationship.
“It is a common assumption that men are the ones who initiate sexual contact within a relationship.”
The paper relies on this without support.
Surgery and radiation treatments are equally effective for early-stage prostate cancer.
“Because surgery and radiation treatments seem to be equally effective in treating early stage prostate cancer, controversy exists about selection of primary treatments for prostate cancer.”
The paper relies on this without support.
The side effects of hormonal therapies are particularly distressing for otherwise asymptomatic men.
“The side effects of hormonal therapies can be particularly distressing for otherwise asymptomatic men.”
The paper relies on this without support.
Many men seek multiple second opinions, and this adds confusion and distress for some because of lack of agreement among practitioners.
“Many men entertain multiple second opinions regarding their primary therapy, though this for some men adds to more confusion and distress because of the lack of agreement among practitioners.”
The paper relies on this without support.
Taking in information from reliable and unverified internet sources can lead to significant anxiety during treatment decision-making.
“They often take in information from reasonable and reliable sources and any number of unverified sources on the internet. This amount of information can lead to significant anxiety while trying to make a reasonable treatment decision.”
The paper relies on this without support.
Fatigue symptoms are particularly upsetting to men who have led active and independent lives.
“Symptoms of fatigue are particularly upsetting to men who have led active and independent lives.”
The paper relies on this without support.
Older men are often reluctant to take pain medications or dosages adequate to alleviate their pain.
“Older men are often reluctant to take pain medications or dosages adequate to alleviate their pain.”
The paper relies on this without support.
Men with prostate cancer respond to education and various kinds of brief psychotherapy, including supportive, cognitive-behavioral, and insight-oriented therapies.
“Men with prostate cancer respond to education and various kinds of brief psychotherapy, including supportive, cognitive-behavioral, and insight-oriented therapies.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Any chosen treatment for prostate cancer is likely to cause incontinence, erectile dysfunction, impaired bowel function and fatigue in patients.
“Although all recommended treatments for prostate cancer take into consideration the age, comorbidities, and probable side effects, any chosen treatment is likely to cause incontinence, erectile dysfunction, impaired bowel function and fatigue in patients.6,7”
From Mindfulness-based interventions for psychological wellbeing and quality of life in men with prostate cancer: A systematic review and meta-analysis (2021) · cites this paper as [6]
The sections on treatment selection and major quality-of-life concerns describe urinary, sexual and bowel effects, as well as fatigue associated with some therapies. They distinguish the effects of different treatments, however, and do not say that any chosen treatment is likely to cause all four problems in a patient. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,811 · see citing works
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455 · see citing works
Zeléfsky, M. J., FUKS, Z. Y., Hunt, M. A., Yamada, Y. J., Marion, C., Ling, C., Amols, H., Venkatraman, E. S., & Leibel, S. A. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02857-2 · Cited by 774 · see citing works
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680 · see citing works
Araujo, A. B., Durante, R., Feldman, H. A., Goldstein, I., & McKinlay, J. B. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199807000-00011 · Cited by 576 · see citing works
Penson, D. F., McLerran, D., Feng, Z., Li, L., Albertsen, P. C., Gilliland, F. D., Hamilton, A. S., Hoffman, R. M., Stephenson, R. A., Potosky, A. L., et al. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154637.38262.3a · Cited by 559 · see citing works
Loblaw, D. A., Virgo, K. S., Nam, R. K., Somerfield, M. R., Ben‐Josef, E., Mendelson, D. S., Middleton, R., Sharp, S. A., Smith, T. J., Talcott, J. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1949 · Cited by 555 · see citing works
Montorsi, F., Luigi, G. G., Strambi, L. F., Da Pozzo, L. F., Nava, L., Barbieri, L., Rigatti, P., Pizzini, G., & Miani, A. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64227-7 · Cited by 547 · see citing works
D'Amico, A. V., Denham, J. W., Crook, J., Chen, M.-H., Goldhaber, S. Z., Lamb, D. S., Joseph, D., Tai, K.-H., Malone, S., Ludgate, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3369 · Cited by 501 · cited 1× · see citing works
“These side effects include: hot flashes, osteoporosis, anemia, fatigue, sarcopenia, gynecomastia, loss of libido, erectile dysfunction (ED), risk of diabetes, risk of cardiovascular disease and fatal cardiac events, and possible emotional distress [9–13].”
BackgroundFACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
RABBANI, F., STAPLETON, A. M. F., KATTAN, M. W., WHEELER, T. M., & SCARDINO, P. T. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)66921-2 · Cited by 487 · see citing works
Litwin, M. S., Lubeck, D. P., Henning, J. M., & Carroll, P. R. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63222-1 · Cited by 401 · see citing works
The carcinogenic risk of treatments for severe psoriasis
Stern, R. S., Laird, N. M., & Study, F. T. P. F.-U. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11 · Cited by 354 · see citing works
Prostate cancer and health‐related quality of life: a review of the literature
Eton, D. T., & Lepore, S. J. (2002) · Psycho-Oncology · doi:10.1002/pon.572 · Cited by 346 · see citing works
Defining sexual outcomes after treatment for localized prostate carcinoma
Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L., Klein, E. A., Zippe, C., & Kupelian, P. A. (2002) · Cancer · doi:10.1002/cncr.10848 · Cited by 305 · see citing works
Increased incidence of depressive symptoms in men with erectile dysfunction
Shabsigh, R., Klein, L. T., Seidman, S., Kaplan, S. A., Lehrhoff, B. J., & Ritter, J. S. (1998) · Urology · doi:10.1016/s0090-4295(98)00292-1 · Cited by 296 · see citing works
WALSH, P. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67547-7 · Cited by 261 · see citing works
Sexuality and Fertility after Cancer
Schover, L. R. (2005) · Hematology · doi:10.1182/asheducation-2005.1.523 · Cited by 257 · see citing works
MULHALL, J. P., SLOVICK, R., HOTALING, J., AVIV, N., VALENZUELA, R., WATERS, W. B., & FLANIGAN, R. C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65303-7 · Cited by 256 · see citing works
HERR, H. W., & O’SULLIVAN, M. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67533-7 · Cited by 250 · see citing works
Bokhour, B. G., Clark, J. A., Inui, T. S., Silliman, R. A., & Talcott, J. A. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.00832.x · Cited by 247 · see citing works
Roth, A. J., Rosenfeld, B., Kornblith, A. B., Gibson, C., Scher, H. I., Curley‐Smart, T., Holland, J. C., & Breitbart, W. (2003) · Cancer · doi:10.1002/cncr.11386 · Cited by 229 · see citing works
Self-citationMulhall, J., Land, S., Parker, M., Waters, W. B., & Flanigan, R. C. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00081_1.x · Cited by 227 · see citing works
Penedo, F. J., Molton, I., Dahn, J. R., Shen, B.-J., Kinsinger, D., Traeger, L., Siegel, S., Schneiderman, N., & Antoni, M. (2006) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm3103_8 · Cited by 223 · see citing works
Dubbelman, Y. D., Dohle, G. R., & Schröder, F. H. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.009 · Cited by 222 · see citing works
Canada, A. L., Neese, L. E., Sui, D., & Schover, L. R. (2005) · Cancer · doi:10.1002/cncr.21537 · Cited by 217 · see citing works
Nicolosi, A., Moreira, E. D., Villa, M., & Glasser, D. B. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.12.008 · Cited by 192 · cited 1× · see citing works
“Two population-based studies with sample sizes over 1700 both reported very similar findings [39,40].”
ResultNerve Sparing Radical Prostatectomy: A Different View
Geary, E. S., Dendinger, T. E., Freiha, F. S., & Stamey, T. A. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67251-3 · Cited by 189 · see citing works
QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
BRANDEIS, J. M., LITWIN, M. S., BURNISON, C. M., & REITER, R. E. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67818-4 · Cited by 188 · see citing works
Communication about prostate cancer between men and their wives.
Boehmer, U., & Clark, J. A. (2001) · PubMed · Cited by 161 · see citing works
Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study
Pirl, W. F., Siegel, G. I., Goode, M. J., & Smith, M. R. (2002) · Psycho-Oncology · doi:10.1002/pon.592 · Cited by 149 · see citing works
PREVENTION AND MANAGEMENT OF ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY
McCullough, A. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70166-x · Cited by 121 · see citing works
Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003) · Medical Care · doi:10.1097/00005650-200301000-00017 · Cited by 119 · see citing works
Andropause: Symptom Management for Prostate Cancer Patients Treated With Hormonal Ablation
Thompson, C. A., Shanafelt, T. D., & Loprinzi, C. L. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-474 · Cited by 84 · see citing works
Mantz, C. A., Song, P., Farhangi, E., Nautiyal, J., Awan, A., Ignacio, L., Weichselbaum, R., & Vijayakumar, S. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00555-x · Cited by 76 · see citing works
Carlsson, S., Aus, G., Wessman, C., & Hugosson, J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.06.002 · Cited by 73 · see citing works
Quality of life after treatment for prostate cancer
Penson, D. F., & Litwin, M. S. (2003) · Current Urology Reports · doi:10.1007/s11934-003-0068-1 · Cited by 71 · see citing works
Quality of Partnership in Patients with Erectile Dysfunction after Sildenafil Treatment
Müller, M. J., Ruof, J., Graf-Morgenstern, M., Porst, H., & Benkert, O. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-14277 · Cited by 66 · see citing works
Treatment ‘mismatch’ in early prostate cancer
Chen, R. C., Clark, J. A., Manola, J. B., & Talcott, J. A. (2007) · Cancer · doi:10.1002/cncr.23138 · Cited by 59 · see citing works
(2004) · PubMed · Cited by 57 · see citing works
Seeking Help for Erectile Dysfunction After Treatment for Prostate Cancer
Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L. E., Klein, E. A., Zippe, C. D., & Kupelian, P. A. (2004) · Archives of Sexual Behavior · doi:10.1023/b:aseb.0000037425.31828.06 · Cited by 56 · see citing works
Deciphering Erectile Dysfunction Drug Trials
Mulhall, J. P. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000063377.12281.57 · Cited by 54 · see citing works
Ene, K. W., Nordberg, G., Johansson, F. G., & Sjöström, B. (2006) · BMC Nursing · doi:10.1186/1472-6955-5-8 · Cited by 45 · see citing works
Klotz, L. H. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0124 · Cited by 44 · see citing works
Riley, A., & Riley, E. (2000) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2000.tb11889.x · Cited by 40 · see citing works
Efficacy and Patient Satisfaction Associated with Penile Prosthesis Revision Surgery
Kava, B., Yang, Y., & Soloway, C. T. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00386.x · Cited by 36 · see citing works
Naoe, M., Ogawa, Y., Shichijo, T., Fuji, K., Fukagai, T., & Yoshida, H. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500891 · Cited by 28 · see citing works
Tsujimura, A., Matsumiya, K., Miyagawa, Y., Takaha, N., Nishimura, K., Nonomura, N., Mori, N., Hara, T., Yamaguchi, S., Takahara, S., et al. (2004) · Urologia Internationalis · doi:10.1159/000078801 · Cited by 24 · see citing works
Making Sense of the Evidence Regarding Nonhormonal Treatments for Hot Flashes
Barton, D., & Loprinzi, C. L. (2004) · Clinical Journal of Oncology Nursing · doi:10.1188/04.cjon.39-42 · Cited by 23 · see citing works
A clinical overview of the treatment of post-prostatectomy incontinence
Dorey, G. (2007) · British Journal of Nursing · doi:10.12968/bjon.2007.16.19.27357 · Cited by 23 · see citing works
Eastham, J. A. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0916 · Cited by 12 · see citing works
(2007) · PubMed · Cited by 9 · see citing works
American Cancer Society's complete guide to prostate cancer
Bostwick, D. G. (2005) · Medical Entomology and Zoology · Cited by 8 · see citing works
8: Predictors of HRQOL Duirng Long-Term Follow-Up of Men Treated for Prostate Cancer
Huang, G. J., Sadetsky, N., Carroll, P. R., et al. (2007) · The Journal of Urology · doi:10.1016/s0022-5347(18)30273-8 · Cited by 8 · see citing works
Lajiness, M. J. (2007) · PubMed · Cited by 1 · see citing works
Rapid screening for psychologic distress in men with prostate carcinoma
Roth, A. J., Kornblith, A. B., Batel-Copel, L., Peabody, E., Scher, H. I., & Holland, J. C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X · DOI · Paper page
Cited by
Sorted by citations
Chung, E., & Brock, G. B. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.03005.x · Cited by 120 · see citing works
Erectile dysfunction after radical prostatectomy
Emanu, J. C., Avildsen, I. K., & Nelson, C. J. (2016) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000195 · Cited by 113 · see citing works
“Both sexual and non-sexual loss of intimacy can occur and lead to relationship distress, conflict, and frustration [38,45].”
BackgroundSelf-citationPsychological aspects of prostate cancer: a clinical review
Sousa, A., Sonavane, S., & Mehta, J. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.66 · Cited by 104 · see citing works
Bowie, J., Brunckhorst, O., Stewart, R., Dasgupta, P., & Ahmed, K. (2021) · Journal of cancer survivorship · doi:10.1007/s11764-021-01007-9 · Cited by 86 · see citing works
“The reasons for this are complex, with anxiety related to treatment decisions [5], distress related to PSA testing [6], and the impact of a cancer diagnosis [7] all likely contributing factors.”
BackgroundLehto, U.-S., Tenhola, H., Taari, K., & Aromaa, A. J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.30 · Cited by 83 · see citing works
“Differences in professional opinion concerning the best treatment option might complicate the situation for the patient at diagnosis (Denberg et al, 2006; Roth et al, 2008; Wever et al, 2013; Sooriakumaran et al, 2014).”
BackgroundInfluentialKinlock, B. L., Parker, L. J., Bowie, J. V., Howard, D. L., Laveist, T. A., & Thorpe, R. J. (2017) · Cancer Control · doi:10.1177/107327481702400112 · Cited by 81 · see citing works
Coping and adjustment in men with prostate cancer: a systematic review of qualitative studies
Spendelow, J. S., Joubert, H. E., Lee, H., & Fairhurst, B. R. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0654-8 · Cited by 74 · see citing works
Lehto, U.-S., Helander, S., Taari, K., & Aromaa, A. J. (2014) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2014.10.018 · Cited by 48 · see citing works
McAteer, G., & Gillanders, D. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13097 · Cited by 47 · see citing works
Morris, B. B., Farnan, L., Song, L., et al. (2015) · Cancer · doi:10.1002/cncr.29309 · Cited by 43 · see citing works
“In addition to this, when first confronted with a CaP diagnosis, men may be less psychologically able to absorb the wealth of treatment information provided and may need this information presented again at a later time or in a variety of ways.(18) The inclusion of nurse navigators may assist in developing this relatio…”
BackgroundBamidele, O. O., McGarvey, H. E., Lagan, B. M., Ali, N., Chinegwundoh, F., Parahoo, K., & McCaughan, E. (2017) · European Journal of Cancer Care · doi:10.1111/ecc.12784 · Cited by 42 · see citing works
Supportive care needs of men with prostate cancer: A systematic review update
Prashar, J., Schartau, P., & Murray, E. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13541 · Cited by 43 · see citing works
Orom, H., Biddle, C., Underwood, W., Homish, G. G., & Olsson, C. A. (2017) · Urology · doi:10.1016/j.urology.2017.08.014 · Cited by 38 · see citing works
Pietilä, I., Jurva, R., Ojala, H., & Tammela, T. L. J. (2018) · Sociology of Health & Illness · doi:10.1111/1467-9566.12671 · Cited by 36 · see citing works
Exercise training improves radiotherapy efficiency in a murine model of prostate cancer
Dufresne, S., Guéritat, J., Chiavassa, S., Noblet, C., Assi, M., Rioux-Leclercq, N. C., Rannou‐Bekono, F., Lefeuvre‐Orfila, L., Paris, F., & Rébillard, A. (2020) · The FASEB Journal · doi:10.1096/fj.201901728r · Cited by 35 · see citing works
Yuan, Y., Hu, Y., Cheng, J.-X., & Ding, P. (2019) · Journal of International Medical Research · doi:10.1177/0300060519878014 · Cited by 33 · see citing works
“All of these negative emotions can further aggravate the psychological distress, affecting daily life and resulting in a vicious cycle of negative feelings.(32) Furthermore, after the removal of Figure 1.”
BackgroundPizzol, D., Xiao, T., Smith, L., Sánchez, G. F. L., Garolla, A., Parris, C. N., Barnett, Y., Ilie, P. C., Soysal, P., Shin, J. I., et al. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x714197 · Cited by 34 · see citing works
Carrier, J., Edwards, D. J., & Harden, J. (2018) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2017-003566 · Cited by 32 · see citing works
A systematic review of disease related stigmatization in patients living with prostate cancer
Larkin, D. T., Birtle, A. J., Bradley, L., Dey, P., Martin, C. R., Pilkington, M., & Romero-Rivas, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261557 · Cited by 35 · see citing works
“As a consequence, however, men diagnosed with prostate cancer are living longer, some with debilitating treatment-related side-effects [6].”
BackgroundRosser, B. R. S., Capistrant, B. D., Torres, B., Konety, B. R., Merengwa, E. N., Mitteldorf, D., & West, W. G. (2016) · Sexual & Relationship Therapy · doi:10.1080/14681994.2016.1228871 · Cited by 31 · see citing works
EDEN, C. G., Moschonas, D., & Soares, R. (2017) · Journal of Clinical Urology · doi:10.1177/2051415817706635 · Cited by 30 · see citing works
İşbilen, Ö., & Volkan, E. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07730 · Cited by 30 · see citing works
“Chemotherapy, the currently preferred method, used along with surgical procedures have severe side effects that can reduce patients' quality of life [2] emphasizing the need to develop novel, direct and integrative therapies.”
MethodZachkani, P., Jackson, J. K., Pirmoradi, F. N., et al. (2015) · RSC Advances · doi:10.1039/c5ra23172h · Cited by 28 · see citing works
Lehto, U.-S., Aromaa, A. J., & Tammela, T. L. J. (2017) · European Journal of Cancer Care · doi:10.1111/ecc.12729 · Cited by 28 · see citing works
“…al., 2009; Lehto, Helander, et al., 2015; Miller et al., 2005; Pardo et al., 2010; Penson, Mclerran, et al., 2008; Penson, Rossignol, et al., 2008; Roth et al., 2008; Sanda et al., 2008; Smith et al., 2007, 2009), and often reduce quality of life also in the patients’ partners and spouses…”
BackgroundBreast and Prostate Cancer Survivor Responses to Group Exercise and Supportive Group Psychotherapy
Martin, E., Bulsara, C., Battaglini, C. L., Hands, B. P., & Naumann, F. (2015) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2015.1082166 · Cited by 27 · see citing works
Nnate, D. A., Anyachukwu, C. C., Igwe, S. E., & Abaraogu, U. O. (2021) · Psycho-Oncology · doi:10.1002/pon.5749 · Cited by 24 · see citing works
“Although all recommended treatments for prostate cancer take into consideration the age, comorbidities, and probable side effects, any chosen treatment is likely to cause incontinence, erectile dysfunction, impaired bowel function and fatigue in patients.(6,7) Hence, a diagnosis of prostate cancer often raises signifi…”
BackgroundReligious Coping and Quality of Life Among Black and White Men With Prostate Cancer
Bruce, M. A., Bowie, J. V., Barge, H., Beech, B. M., LaVeist, T. A., Howard, D. L., & Thorpe, R. J. (2020) · Cancer Control · doi:10.1177/1073274820936288 · Cited by 25 · see citing works
“Prostate cancer diagnosis and treatment has been linked to a number of psychological (eg, anxiety, depression), physical (eg, erectile dysfunction, urinary incontinence), and social (eg, loss of social support, financial burden) issues that can adversely impact overall quality of life.(8,10-17) Research examining the…”
ResultShin, D., Park, H. S., Lee, S. H., Jeon, S., Cho, S., Kang, S., Park, S. C., Park, J. H., & Park, J. (2018) · Cancer research and treatment : official journal of Korean Cancer Association · doi:10.4143/crt.2018.053 · Cited by 22 · see citing works
Yanez, B. R., Bustillo, N. E., Antoni, M. H., Lechner, S. C., Dahn, J. R., Kava, B., & Penedo, F. J. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-014-9594-1 · Cited by 23 · see citing works
“Elevated anxiety during PC screening and PSA monitoring is well documented in the literature (Dale et al., 2005; Roth et al., 2008) suggesting that men undergoing active surveillance may not experience continuous elevated levels of anxiety; instead, anxiety may rise during PSA testing and upon notification of rising P…”
Wang, C., Song, Z., Li, S., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3988-x · Cited by 22 · see citing works
“It was demonstrated that psychological intervention had a great significance for the improvement of the patients’ subjective feelings and quality of life [30, 31].”
BackgroundLange, L., Fink, J., Bleich, C., Graefen, M., & Schulz, H. (2017) · Internet Interventions · doi:10.1016/j.invent.2017.06.001 · Cited by 22 · see citing works
Shin, D., Lee, S. H., Kim, T.-H., Yun, S., Nam, J. K., Jeon, S., Park, S. C., Jung, S., Park, J.-H., & Park, J. (2018) · Cancer research and treatment : official journal of Korean Cancer Association · doi:10.4143/crt.2018.221 · Cited by 8 · see citing works
Baba, N., Schrage, T., Hartmann, A., Baba, K., Wünsch, A., Schultze‐Seemann, W., Weis, J., & Joos, A. A. B. (2020) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217420938896 · Cited by 21 · see citing works
Krausewitz, P., Bundschuh, R. A., Gaertner, F. C., Essler, M., Attenberger, U. I., Luetkens, J. A., Kristiansen, G., Muders, M. H., Ohlmann, C., Hauser, S., et al. (2023) · Trials · doi:10.1186/s13063-023-07197-0 · Cited by 22 · see citing works
“PCA and its treatment affect patients’ quality of life in several areas [1, 2].”
BackgroundBender, J. L., Flora, P. K., Soheilipour, S., Dirlea, M., Maharaj, N., Parvin, L., Matthew, A., Catton, C., Jamnicky, L., Pollock, P., et al. (2022) · Current Oncology · doi:10.3390/curroncol29060343 · Cited by 23 · see citing works
Krausewitz, P., Kluemper, N., Richter, A.-P., et al. (2022) · Cancers · doi:10.3390/cancers14184355 · Cited by 17 · see citing works
“Fear and distress in men undergoing evaluation for PCa are frequent and affect their quality of life [1].”
BackgroundMental health outcomes in a population-based cohort of patients with prostate cancer
Hu, S., Chang, C.-P. E., Snyder, J., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad175 · Cited by 17 · see citing works
Rice, S., Kealy, D., Ogrodniczuk, J. S., Seidler, Z. E., Denehy, L., & Oliffe, J. L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s237770 · Cited by 16 · see citing works
Fernández‐Sola, C., Martínez-Bordajandi, Á., Puga-Mendoza, A. P., Hernández‐Padilla, J. M., Fischer, V. J., López‐Rodriguez, M. M., & Granero‐Molina, J. (2020) · American Journal of Men s Health · doi:10.1177/1557988320906977 · Cited by 16 · see citing works
“The establishment of support groups in other countries has been proposed as a model for programs for prostate cancer patients (Roth et al., 2008).”
BackgroundEducating Our Patients Collaboratively: A Novel Interprofessional Approach
Reinhart, R., D’Alimonte, L., Osmar, K., et al. (2014) · Journal of Cancer Education · doi:10.1007/s13187-014-0623-0 · Cited by 15 · see citing works
Gjerset, G. M., Fosså, S. D., Dahl, A. A., Loge, J. H., Ensby, T., & Thorsen, L. (2011) · Journal of Cancer Education · doi:10.1007/s13187-011-0245-8 · Cited by 14 · see citing works
“However, many PCa survivors experience late effects caused by the disease and/or the treatment like decreased physical function, increased body fat mass [3], impairment of bladder, bowel, or sexual function [4], fatigue, depression, and reduced quality of life (QoL) [5].”
BackgroundRetzius-sparing robotic radical prostatectomy
Eden, C. (2019) · Asian Journal of Andrology · doi:10.4103/aja.aja_82_19 · Cited by 14 · see citing works
Levesque, J. V., Lambert, S., Girgis, A., Turner, J., McElduff, P., & Kayser, K. (2015) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/2347-5625.160969 · Cited by 14 · see citing works
“There is also growing evidence of the numerous psychosocial challenges for partners dealing with prostate cancer, including emotional distress, psychosexual and relational changes, assisting the patient to adjust to treatment-related side effects and an altered view of the future.([6,7,9,17,18]) Hawes et al.”
BackgroundSalonia, A., Zanni, G. E., Andrea Gallina, A., Briganti, A., Saccà, A., Suardi, N. R., Matloob, R., Pozzo, L. D., Bertini, R., Colombo, R., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01483.x · Cited by 14 · see citing works
Lunger, L., Meissner, V. H., Kopp, B. C. G., Dinkel, A., Schiele, S., Ankerst, D. P., Gschwend, J. E., & Herkommer, K. (2023) · BMC Urology · doi:10.1186/s12894-023-01311-9 · Cited by 13 · see citing works
“Although the internet provides patients with an uncomplicated access to information, most sources are unverified and uncontrolled, causing significant anxiety and distress while seeking to make the best treatment decision [30, 32].”
BackgroundSymptom and function profiles of men with localized prostate cancer
Reeve, B. B., Tan, X. M., Chen, R. C., Usinger, D., & Pinheiro, L. C. (2018) · Cancer · doi:10.1002/cncr.31401 · Cited by 12 · see citing works
“This study (10-1483) was approved by the University of North Carolina Institutional Review Board.”
MethodMsaouel, P., Gralla, R. J., Jones, R. A., & Hollen, P. J. (2017) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2016-001146 · Cited by 11 · see citing works
Communication networks of men facing a diagnosis of prostate cancer
Brown, D., OETZEL, J. G., & Henderson, A. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13369 · Cited by 12 · see citing works
Adam, S., Doege, D., Koch‐Gallenkamp, L., Thong, M. S. Y., Bertram, H., Eberle, A., Holleczek, B., Pritzkuleit, R., Waldeyer‐Sauerland, M., Waldmann, A., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05120-5 · Cited by 12 · see citing works
Self‐reported barriers to mental health treatment among men with prostate cancer
Weinberger, M. I., Nelson, C. J., & Roth, A. J. L. (2010) · Psycho-Oncology · doi:10.1002/pon.1775 · Cited by 11 · see citing works
Self-citationJurys, T., & Durmała, J. (2021) · Scandinavian Journal of Urology · doi:10.1080/21681805.2021.1871644 · Cited by 11 · see citing works
Andkhoie, M., Meyer, D., & Szafron, M. (2018) · Canadian Urological Association Journal · doi:10.5489/cuaj.5538 · Cited by 11 · see citing works
Park, J., Thomas, S., Zhong, A. Y., Wolfe, A. R., Krings, G., Terranova-Barberio, M., Pawłowska, N., Benet, L. Z., & Münster, P. N. (2018) · Scientific Reports · doi:10.1038/s41598-017-18436-1 · Cited by 9 · see citing works
Activating Technology for Connected Health in Cancer: Protocol for a Research and Training Program
Mountford, N., Dorronzoro-Zubiete, E., Kessie, T., et al. (2018) · JMIR Research Protocols · doi:10.2196/resprot.8900 · Cited by 9 · see citing works
“All contribute to reducing the overall QoL (Quality Of Life)[5], the very thing that we are seeking to maximize within cancer-recovery cohorts (see studies in breast cancer [6], [7] and prostate cancer [8],[9]).”
Kinnaird, W., Kirby, M. G., Mitra, A., Davda, R., Jenkins, V. A., & Payne, H. A. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13873 · Cited by 9 · see citing works
Persson, B., GITTELMAN, M. C., Brown, T. M., et al. (2011) · UroToday International Journal · doi:10.3834/uij.1944-5784.2011.12.14 · Cited by 8 · see citing works
Fear of cancer recurrence among patients with localized prostate cancer
Bergerot, C. D., Williams, S. B., & Klaassen, Z. W. A. (2021) · Cancer · doi:10.1002/cncr.33837 · Cited by 8 · see citing works
Hilger, C., Otto, I., Hill, C., Huber, T. F., & Kendel, F. (2018) · Der Urologe · doi:10.1007/s00120-018-0769-1 · Cited by 8 · see citing works
Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review
Khalili, N., Keshavarz‐Fathi, M., Shahkarami, S., Hirbod‐Mobarakeh, A., & Rezaei, N. (2018) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155218808080 · Cited by 7 · see citing works
Harju, E., Rantanen, A., Kaunonen, M., Helminen, M., Isotalo, T., & Åstedt-Kurki, P. M. (2017) · International Journal of Nursing Practice · doi:10.1111/ijn.12572 · Cited by 7 · see citing works
Hedden, L., Pollock, P., Bryan, S., Goldenberg, L., & Higano, C. S. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04927-6 · Cited by 6 · see citing works
de Valois, B. A., Young, T., Thorpe, P., Preston, J., & Degun, T. (2015) · Medical Acupuncture · doi:10.1089/acu.2014.1086 · Cited by 6 · see citing works
Morgan, L., Carrier, J., & Edwards, D. J. (2015) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2015-2408 · Cited by 6 · see citing works
Hou, S., Qiao, W., Li, Y., He, H., Wu, B., Dai, Y., & Wang, W. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01706-z · Cited by 5 · see citing works
“These persistent side effects contribute to a heightened symptom burden, which is often associated with negative emotional states and diminished self-efficacy [7, 8].”
El-Haouly, A., Dragomir, A., El-Rami, H., Liandier, F., & Lacasse, A. (2020) · Canadian Urological Association Journal · doi:10.5489/cuaj.6521 · Cited by 5 · see citing works
Impact of prostate biopsy secondary pathology review on radiotherapy management
Siedow, M. R., Eisner, M., Yaney, A., Washington, I. R., Zynger, D. L., Martin, D., Mo, X. M., Diconstanzo, D., & Diaz, D. A. (2021) · The Prostate · doi:10.1002/pros.24260 · Cited by 5 · see citing works
Development, implementation, and evaluation of a prostate cancer supportive care program
Hedden, L. (2018) · The Journal of Community and Supportive Oncology · doi:10.12788/jcso.0438 · Cited by 3 · see citing works
Preyde, M., Kukkonen, T. M., & Cunningham, C. A. (2020) · Social Work in Health Care · doi:10.1080/00981389.2020.1818668 · Cited by 3 · see citing works
Evaluating Quality of Life of Prostate Cancer Patients After Radical Prostatectomy
Bakalis, V. I. (2025) · Cureus · doi:10.7759/cureus.79973 · Cited by 2 · see citing works
“A diagnosis of prostate cancer is associated with physical, psychological, emotional, social, and financial hardships and negatively impacts the QoL of men suffering from this condition [15,16].”
Lehto, U.-S., Aromaa, A. J., & Tammela, T. L. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-063435 · Cited by 2 · see citing works
Savaş, E., & ÖZMEN, S. (2024) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2023-100197 · Cited by 2 · see citing works
Psychoonkologische Aspekte urologischer Tumorerkrankungen
Berberich, H. J., & Buntrock, S. (2016) · Springer eBooks · doi:10.1007/978-3-642-39940-4_22 · Cited by 2 · see citing works
Active Surveillance and Patient Support Intervention
Parker, P. A., Kim, J., & Latini, D. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-32641-2_30 · Cited by 2 · see citing works
Arogundade, A. K., Ajape, A. A., Popoola, A. A., Abiola, O. O., & Biliaminu, S. A. (2022) · Rwanda medical journal · doi:10.4314/rmj.v79i1.2 · Cited by 1 · see citing works
“Androgen deprivation therapy (ADT) remains the cornerstone of treatment in men with advanced disease [4,7].”
BackgroundHoltman, A. L., van Leersum, S., van den Berg, K. S., Dijksman, L. M., Freeze, W. M., Scheltema, M. J. V., Hunting, J. C. B., & Hegeman, J. M. (2025) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2025.112350 · Cited by 1 · see citing works
Runtunuwu, S. V. B. E., Tallei, T. E., Kim, H. J., Park, M. N., Çeli̇k, İ., Kirilmaz, B., Turalaki, G. L. A., Fatimawali, F., Tendean, L. E. N., Kaseke, M. M., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1716345 · Cited by 1 · see citing works
“However, these therapies are associated with significant side effects, such as sexual dysfunction, fatigue, and increased risk of cardiovascular disease, which impact patients’ quality of life (4).”
Navigating work after prostate cancer treatment: a systematic review of qualitative research
Tomic, D., Keegel, T. G., Schellack, S. K., Abdel-Malek, L., Jander, C., Hettige, S. T., MacFarlane, E., Millar, J. W. L., & Walker-Bone, K. E. (2026) · Journal of Cancer Survivorship · doi:10.1007/s11764-026-02062-w · Cited by 1 · see citing works
García-Miralles, N., Martínez‐García, I., Marcilla-Toribio, I., Herreros-Solano, A., Fernández‐Bravo‐Rodrigo, J., Patiño‐Cardona, S., Moreno-Charco, E., Ortega-Armiñana, A. M., Gregori-Navarro, M., & Pascual‐Morena, C. (2026) · Healthcare · doi:10.3390/healthcare14131998 · Cited by 1 · see citing works
Chipiti, T., Molefi, T., Demetriou, D., Lolas, G., & Dlamini, Z. (2024) · Springer eBooks · doi:10.1007/978-3-031-64388-0_11 · Cited by 1 · see citing works
Retzius‐sparing robot‐assisted radical prostatectomy
EDEN, C. G. (2018) · Trends in Urology & Men s Health · doi:10.1002/tre.652 · Cited by 1 · see citing works
Post-treatment impact and needs of prostate cancer survivors in Malaysia; a qualitative study.
Lee, P. Y., Ng, C. J., TA, O., Yk, L., Khatijah Lim, A., Cheong, A. T., & Hassan, A. (2017) · PubMed Central · Cited by 1 · see citing works
Côté, K. A. (2015) · Lu Zone Ul (Laurentian University) · Cited by 1 · see citing works
Rehabilitation in cancer survivors - with focus on physical activity
Gjerset, G. M. (2012) · NORA - Norwegian Open Research Archives · Cited by 1 · see citing works
Bamidele, O. O. (2019) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1 · see citing works
Kapfhammer, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-68309-5_5 · Cited by 1 · see citing works
Bellardita, L., Rancati, T., & Valdagni, R. (2013) · International Journal of Urology · doi:10.1111/iju.12342
Walsh, D. M. J. (2015) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17845
Martin, E. (2014) · ResearchOnline@ND (The University of Notre Dame)
Communication Networks of Men with Prostate Cancer
Brown, D. (2013) · Research Commons (University of Waikato)
Educating our Patients Collaboratively: A Novel InterProfessional Approach
Reinhart, R., D’Alimonte, L., Bristow, B., et al. (2012) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2012.03.009
Prostate Cancer National Summit’s Call to Action
Heath, E. I., Nanus, D. M., Slovin, S. F., Strand, C., Higano, C. S., Simons, V. H., Johnson, C., Kyriakopoulos, C. E., Reichert, Z. R., Lory, S., et al. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.04.002
“55,56 The American Cancer Society presented a detailed summary of the long-term effects associated with different prostate cancer treatments, including increased risk of urinary, bowel, and sexual dysfunctions.”
BackgroundMcGrowder, D., Miller, F. G., Brown, J., Wilson-Clarke, C., & Anderson-Jackson, L. (2021) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-6527-8.ch007
Perceptions towards diagnosis of prostate cancer in Tharaka Nithi County, Kenya
Kirungia, T. K., Kirigia, C., Gitonga, L. K., & Kiruki, S. (2021) · Journal Of Nursing Practice · doi:10.30994/jnp.v4i2.126
“According to Roth et al (2008) PCa is the most prevalent type of cancer among males in the United States with an estimated 218,000 new cases of prostate cancer being diagnosed and 27,000 patients succumbing from the ailment every year.”
BackgroundQuality of Life versus Length of Life: Are Cancer Patients' Preferences Stable Over Time?
Paton, C. (2011) · Otago University Research Archive (University of Otago)
Psychoonkologische Aspekte urologischer Tumorerkrankungen
Berberich, H. J., Buntrock, S., & Dräger, D. L. (2022) · Springer Reference Medizin · doi:10.1007/978-3-642-41168-7_22-2
- Authors
- Roth, A. J., Weinberger, M. I., & Nelson, C. J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- NewYork–Presbyterian Hospital (US)
- Venue
- Future Oncology
- Publisher
- Informa UK Limited
- Published
- 2008-08-06
- Volume
- 4
- Issue
- 4
- Pages
- 561-568
- ISSN
- 1479-6694 (ISSN-L)
- 1744-8301
- PMC
- PMC2796196
- OpenAlex
- W2058452247
- Cited by
- 113
- References
- 55
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 12 · 2016: 6 · 2015: 8 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 0.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Future Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (T32MH073553)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Keywords
- prostate cancer, psychosocial problems, quality of life, older adults, prostate cancer screening, treatment side effects, psychiatric management, psychological management, treatment decision-making
- MeSH terms
- Adenocarcinoma, Adult, Age Factors, Aged, Fatigue, Fear, Humans, Erectile Dysfunction, Interpersonal Relations, Male, Mass Screening, Middle Aged, Pain, Patient Acceptance of Health Care, Postoperative Complications, Prostatectomy, Prostatic Neoplasms, Psychology, Psychotherapy, Quality of Life, Urinary Incontinence, Antineoplastic Agents, Hormonal, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
